Clinical Trials

Inclusion Criteria:

1. Participant must be suspected of having or is known to have a tumor within/of the nervous system or other disease of the nervous system
2. Participant, or participant’s authorized legal representative, must consent to the following:
   1. Banking of previously obtained and collection of future unused tissue, blood, and skin during surgery
   2. Providing minimal risk samples just for research purposes, such as blood, buccal swab, and urine during or outside of routine medical procedure
   3. Collection of clinical information, including PHI, from medical records, scans (radiographic neuroimages), and laboratory results
   4. Linkage of clinical information to collected tissues
   5. Providing samples and records from other institutions
   6. Use of samples for the creation of cell lines, genetic testing including whole genome sequencing as well as other available sequencing techniques, research testing (techniques under development), and that samples may be stored indefinitely until used
   7. Use of data and samples to study neurologic diseases and their treatment
   8. Notification of results that may be clinically relevant via their clinician
   9. Derivative products of value may arise for which participants will not have any financial benefit
   10. Participants may withdraw from the study at any time, however data and samples already collected may not be recalled or destroyed
   11. Samples and data to be shared with outside institutions including commercial entities, but samples will never be sold

Exclusion Criteria:

1. No exclusion criteria are specified